nContact Surgical Inc. aims to merge the best of surgical and interventional techniques to provide a truly minimally invasive, single procedure solution for atrial fibrillation patients. Its Numeris Coagulation system with VisiTrax is used in the surgical portion of the procedure, in which VisiTrax integrates suction, perfusion and radiofrequency energy to create long linear lesions on the outside of a beating heart. The electrophysiologist then uses a catheter to complete the biatrial lesion pattern inside the heart.
Article preview from Start Up - June, 2010
nContact Surgical Inc. aims to merge the best of surgical and interventional techniques to provide a truly minimally invasive, single procedure solution for atrial fibrillation patients. Enabled by its endoscopic epicardial ablation devices, its convergent procedure is being evaluated for the treatment of atrial fibrillation in a fully closed-chest approach, without any incisions or ports. The procedure is performed in a single setting, usually in the electrophysiology lab.
The Numeris-AF Coagulation System with VisiTrax is used in the surgical portion of the procedure, in which VisiTrax integrates suction, perfusion and radiofrequency energy to create long linear lesions on the outside of a beating heart. The electrophysiologist then uses a catheter via the femoral arteries to complete the biatrial lesion pattern inside the heart.
"The convergent procedure enables ablation on both the inside and the outside of the heart," says John Funkhouser, president and CEO of nContact. "As a result, the reentrant circuits that are causing the problem can be isolated." Furthermore, the EP can perform diagnostic tests intraoperatively to "ensure that all of these areas of the heart have in fact been isolated and that these circuits have been interrupted," Funkhouser states.
Purchase this article online or get it FREE when you subscribe to Start Up
Companies mentioned in this article:
nContact Surgical Inc.
Elsevier Business Intelligence announces the publication of a new Special Report "Bigger, Tougher,Faster"- Preparing for the New FDA. When the inspector comes calling ... will you be ready?
This 16-page report originally published in "The Silver Sheet". Learn more...
About Start Up
No publication reviews leading edge companies and technology better than START-UP. Each issue of START-UP profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics.
Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985 9512
Comments